Neurophysiology Biomarkers of Cognitive Impairment Associated With Deep Brain Stimulation
NCT: NCT05933681 · ACTIVE_NOT_RECRUITING
Brief Summary
The study aims to investigate cognitive impairment associated with Deep Brain Stimulation (DBS) in Parkinson's Disease patients, with a focus on identifying neurophysiology biomarkers of DBS associated cognitive changes. Using neurophysiology data recorded during DBS surgeries and post-implantation, the research intends to identify biomarkers in order to optimize electrode placement, enhance programming, and ultimately minimize DBS-related cognitive side effects.
Frequently Asked Questions
What is Neurophysiology Biomarkers of Cognitive Impairment Associated With Deep Brain Stimulation?
Neurophysiology Biomarkers of Cognitive Impairment Associated With Deep Brain Stimulation is a clinical trial registered under NCT05933681. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT05933681?
The current status of NCT05933681 (Neurophysiology Biomarkers of Cognitive Impairment Associated With Deep Brain Stimulation) is: ACTIVE_NOT_RECRUITING.
When did Neurophysiology Biomarkers of Cognitive Impairment Associated With Deep Brain Stimulation start?
Neurophysiology Biomarkers of Cognitive Impairment Associated With Deep Brain Stimulation started on 2023-07-06.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.